Safety and Efficacy of a Novel Sealant‐Based Vascular Closure Device Following Electrophysiology Procedures: ReliaSeal Trial.
Background: While manual compression (MC) remains the standard of care to achieve hemostasis, a novel vascular closure device (VCD) was designed to achieve faster hemostasis without compromising safety. The objective of the ReliaSeal trial was to evaluate the safety and effectiveness of the Mynx Con...
| Publicado en: | Journal of Cardiovascular Electrophysiology Vol. 36; no. 5; pp. 1022 - 1032 |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , |
| Formato: | diagnostic images research tables/charts randomized controlled trial Journal Article |
| Publicado: |
Wiley-Blackwell
May2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |